Avalon Pharma sign at the company headquarters

Corporate Governance

Shareholders

The procedures taken by the Board of Directors to inform its members particularly the non-executive members of shareholders’ proposals and observations regarding the Company and its performance

The Investor Relations Unit serves as the link between the Board of Directors and the shareholders. The Company’s governance regulations also include the Board of Directors’ working procedures, which give special attention to receiving and responding to shareholders’ proposals and inquiries through email at investor.relations@avalon.com.sa and by telephone at +966118365000, extension 3374.

General Assembly Meetings of Shareholders During 2025

Scroll horizontally to view every table column.

General Assembly Meetings of Shareholders During 2025
No.Member NamePositionMeeting Date 29/05/2025
1Ahmed Shaher Al TabbaaChairperson of the Board✔️
2Hisham Mohammed AttarVice Chairperson of the Board✔️
3Faisal Sulamin AljamaanBoard Member✔️
4Omar Mohammed Saib AljaroudiBoard Member✔️
5Mohamed Maher AlghannamChief Executive Officer and Managing Director✔️

Number of the Company’s requests for shareholders’ records, their dates, and reasons.

Scroll horizontally to view every table column.

Number of the Company’s requests for shareholders’ records, their dates, and reasons.
NumberRequest DateReason for Request
107/05/2025Cash Dividend Distribution
229/05/2025General Assembly of Shareholders
330/06/2025External Auditor
402/07/2025External Auditor

Penalties and Sanctions

Details of any penalties or preventive measures imposed by regulatory or judicial authorities on the Company, including an explanation of the reasons for the violation, the authority responsible for imposing the penalty, and the steps taken to rectify the situation and prevent recurrence in the future.

No penalties, preventive measures, or sanctions were imposed on the Company during the year 2025 .